logo

FDA Calendar

Share
Company Name Regeneron Pharmaceuticals
Drug Name REGN-EB3 (BLA)
Event Name FDA decision on REGN-EB3 for Ebola virus infection
Event Date 10/25/2020
Outcome Date
Outcome
Drug Status Priority review
Rival Drugs
Market Potential
Other Approvals
News
Return to FDA Calendar